Study on pathogenesis of schistosomal liver fibrosis

Study on pathogenesis of schistosomal liver fibrosis

The important pathological feature induced by schistosomiasis is liver fibrosis. Schistosome eggs release soluble egg antigen to form egg granuloma, which stimulates host inflammation, induces extracellular matrix deposition, and finally causes liver fibrosis. This process is tightly associated with...

Full description

Bibliographic Details
Main Author:	ZHAO Lei
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2015-03-01
Series:	Linchuang Gandanbing Zazhi
Subjects:	schistosomiasis；liver cirrhosis；cytokines
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=6361&ClassID=212131135

Similar Items

Myofibroblasts in Schistosomal Portal Fibrosis of Man
by: Andrade Zilton A, et al.
Published: (1999-01-01)

Hyperplasia of elastic tissue in hepatic schistosomal fibrosis
by: Zilton A. Andrade, et al.
Published: (1991-12-01)

Pathogenesis and new therapeutic targets of liver fibrosis
by: ZHANG Wei, et al.
Published: (2017-03-01)

Recent research on liver fibrosis and cirrhosis
by: LU Lungen
Published: (2013-05-01)

Emerging Role of HMGB1 in the Pathogenesis of Schistosomiasis Liver Fibrosis
by: Amanda R. R. Vicentino, et al.
Published: (2018-09-01)

Low transformation growth factor-β1 production and collagen synthesis correlate with the lack of hepatic periportal fibrosis development in undernourished mice infected with Schistosoma mansoni
by: Andreia Ferreira Barros, et al.
Published: (2014-04-01)

Recent progress in understanding the role of microRNAs in hepatic stellate cell biology and liver fibrosis pathogenesis
by: LI Binbin
Published: (2013-05-01)

Schistosome-Associated Pulmonary Arterial Hypertension: A Review Emphasizing Pathogenesis
by: Teresa Cristina Abreu Ferrari, et al.
Published: (2021-10-01)

Differential Regulation of Granuloma Size and Hepatic Fibrosis in Schistosome Infections
by: Allen W Cheever
Published: (1997-09-01)

Host Regulators of Liver Fibrosis During Human Schistosomiasis
by: Severin Donald Kamdem, et al.
Published: (2018-11-01)

Mechanisms and treatment of cholestasis-induced liver fibrosis
by: ZHANG Qidi
Published: (2015-03-01)

The critical importance of diagnosing and treating liver fibrosis
by: GUO Jinsheng
Published: (2018-01-01)

Reversal of liver fibrosis
by: Ismail Mona, et al.
Published: (2009-01-01)

Proteome analysis of liver nonparenchymal cells from rats with alcoholic liver fibrosis
by: ZHANG Lijun
Published: (2014-10-01)

Pathogenesis of congenital hepatic fibrosis and current status of its diagnosis and treatment
by: FENG Maosen, et al.
Published: (2017-03-01)

Pathological assessment of liver fibrosis regression
by: WANG Bingqiong, et al.
Published: (2017-03-01)

Prevention and treatment of liver fibrosis by regulating liver regeneration
by: LI Hanmin
Published: (2015-06-01)

Behind Enemy Lines: Immunomodulatory Armamentarium of the Schistosome Parasite
by: Jose Ma. M. Angeles, et al.
Published: (2020-06-01)

STAT3: A key regulator in liver fibrosis
by: Jie Zhao, et al.
Published: (2021-03-01)

Novel molecular diagnostic markers for liver fibrosis
by: DU Jinghua, et al.
Published: (2017-03-01)

Serum hyaluronan and collagen IV as non-invasive markers of liver fibrosis in patients from an endemic area for schistosomiasis mansoni: a field-based study in Brazil
by: Carolina Coimbra Marinho, et al.
Published: (2010-07-01)

The host-parasite relationship of schistosomes in mice
by: Mubarak, Jamil Salim
Published: (1996)

Biomarkers for liver fibrosis: Advances, advantages and disadvantages
by: A. Cequera, et al.
Published: (2014-07-01)

Targeted therapy of liver fibrosis on the horizon
by: CHEN Pingsheng
Published: (2013-11-01)

Role of liver sinusoidal endothelial cells in the development and progression of liver fibrosis and related therapeutic strategy
by: WU Jun, et al.
Published: (2017-03-01)

CYTOKINE PROFILE IN PATIENTS WITH CHRONIC VIRUS HEPATITIS COMPLICATED WITH FIBROSIS AND CIRRHOSIS
by: E. R. Chernykh, et al.
Published: (2014-07-01)

Liver morphological changes and proinflammatory cytokines in experimental animals in case of cirrhosis
by: O. I. Romak, et al.
Published: (2017-03-01)

Research advances in association between matrix metalloproteinases and liver fibrosis
by: GE Hongyan, et al.
Published: (2017-03-01)

Non-invasive diagnosis of liver fibrosis by FibroScan imaging
by: WANG Chunyan
Published: (2013-03-01)

Management Strategies for Liver Fibrosis
by: Alejandra Altamirano-Barrera, et al.
Published: (2017-01-01)

Liver Fibrosis and Inflammation under the Control of ERK2
by: Kuo-Shyang Jeng, et al.
Published: (2020-05-01)

Hepatic fibrosis in nonalcoholic fatty liver disease and its quantitative assessment
by: WANG Yan
Published: (2017-12-01)

Remodeling of hepatic vascular changes after specific chemotherapy of schistosomal periportal fibrosis
by: Zilton A Andrade, et al.
Published: (2006-10-01)

Influence of different types of cell senescence on the development and progression of liver fibrosis
by: GUO Shan, et al.
Published: (2018-03-01)

Genistein decreases liver fibrosis and cholestasis induced by prolonged biliary obstruction in the rat
by: Alfonso Leija Salas, et al.
Published: (2007-01-01)

Antiviral therapy for recurrent hepatitis C after liver transplantation and its effect on liver fibrosis
by: ZHOU Shuangnan
Published: (2014-01-01)

Research advances in serum markers for alcoholic liver fibrosis
by: ZHANG Yanfang, et al.
Published: (2018-03-01)

Induction of immunity in mice by the radiation attenuated schistosome vaccine
by: Anderson, Sonia
Published: (1996)

An excerpt of Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis(2016)
by: DENG Chaowen, et al.
Published: (2017-03-01)

Schistosome Infections: An Indian Perspective
by: Arunava Kali
Published: (2015-02-01)